Novo Nordisk A/S
DEEURNovo Nordisk A/S (US:NONOF) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 3. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.
- Novo Nordisk A/S — NOVO-B · CO DK Registarski broj nepoznat
O Tvrtki
- Web-Stranica
- novonordisk.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sjedište
- BAGSVAERD DENMARK, Denmark
- Glavni Direktor
- Maziar Mike Doustdar
- Zaposlenici
- 66 700
- Dionice u Optjecaju
- 3.34 mlrd.
- Slobodno Prenosive Dionice
- 3.17 mlrd.
- Tržišna Kapitalizacija
- 150.93 mlrd. EUR
- Insajderi
- 5.27%
- Institucionalni Ulagači
- 33.78%
- Djelatnost (SIC)
- Pharmaceutical Preparations
- Pravni Oblik
- ZRPO
- ISIN
- DK0060534915
- LEI
- 549300DAQ1CVT6CXN342
- Omjer Isplate
- 50.5%
- FCF
- 59.0 mlrd. DKK
- Isplata / FCF
- 88%
- Dug
- 143 mlrd. DKK2.0 g. FCF
- Dividendni Staž
- 24 g.
- Zarada, FCF i isplaćene dividende — za 12 mjeseci do 31.12.2025 (najnovije izvješće tvrtke).
Opis
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. The company has a collaboration with Anthropic accelerate the development of new medicines and advance AI-driven software development. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. It has a strategic collaboration with Orbis Medicines to discover and develop oral macrocycle therapeutics for cardiometabolic diseases. The company was formerly known as Novo Industri A/S and changed its name to Novo Nordisk A/S in April 1989. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Dividende
Novo Nordisk A/S (NONOF) isplaćuje dividende dvaput godišnje. Godišnje (12 mjeseci do uključivo posljednje najavljene isplate): 11.7 DKK po dionici (isplata: 2). Prema povijesti isplata, sljedeći datum ex-dividende očekuje se oko 15.02.2027. Godine neprekinutih dividendi: 24.
| Ex-Datum | Isplata | Iznos | % | Vrsta | Oznaka |
|---|---|---|---|---|---|
| 2026-08-17 | 2026-08-18 | 3.7500 DKK | 1.2/3.9 % | polugodišnji | US:NONOF |
| 2026-03-30 | 2026-03-31 | 7.9500 DKK | 3.4/5.0 % | polugodišnji | US:NONOF |
| 2025-08-18 | 2025-08-19 | 3.7500 DKK | 1.1/3.4 % | polugodišnji | US:NONOF |
| 2025-03-31 | 2025-04-01 | 7.9000 DKK | 1.7/2.5 % | polugodišnji | US:NONOF |
| 2024-08-16 | 2024-08-19 | 3.5000 DKK | 1.4/3.8 % | polugodišnji | US:NONOF |
| 2024-03-22 | 2024-03-26 | 6.4000 DKK | 2.5/≈4.9 % | polugodišnji | US:NONOF |
Najveći Imatelji
| Imatelj | Udio | Dionice | Datum Izvješća |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.38% | 46.88 mil. | 2026-07-31 |
| EuroPacific Growth Fund-… | 1.07% | 36.2 mil. | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.92% | 31.13 mil. | 2026-06-30 |
| Capital World Growth & I… | 0.77% | 26.02 mil. | 2026-06-30 |
| iShares Trust-iShares Co… | 0.71% | 24.13 mil. | 2026-08-31 |
| Income Fund of America | 0.52% | 17.78 mil. | 2026-07-31 |
| Dodge & Cox Funds-Dodge… | 0.39% | 13.1 mil. | 2026-06-30 |
| Fidelity Concord Street… | 0.37% | 12.52 mil. | 2026-07-31 |
| iShares Trust-iShares MS… | 0.34% | 11.48 mil. | 2026-08-31 |
| Capital Income Builder | 0.3% | 10.32 mil. | 2026-07-31 |
| Cygnus Capital Advisors,… | 0% | 78 800 | 2026-06-30 |
| Generali Investments Cee… | 0% | 27 399 | 2026-06-30 |
| Pacer Advisors, Inc. | 0% | 24 410 | 2026-06-30 |
| Atlas Capital Advisors I… | 0% | 5 218 | 2026-06-30 |
| Novo Holdings | — | — | — |
| Novo Nordisk Foundation | — | — | — |
